116 related articles for article (PubMed ID: 22265660)
21. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.
Akundi RS; Huang Z; Eason J; Pandya JD; Zhi L; Cass WA; Sullivan PG; Büeler H
PLoS One; 2011 Jan; 6(1):e16038. PubMed ID: 21249202
[TBL] [Abstract][Full Text] [Related]
22. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress.
Gautier CA; Kitada T; Shen J
Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11364-9. PubMed ID: 18687901
[TBL] [Abstract][Full Text] [Related]
23. Parkinson patient fibroblasts show increased alpha-synuclein expression.
Hoepken HH; Gispert S; Azizov M; Klinkenberg M; Ricciardi F; Kurz A; Morales-Gordo B; Bonin M; Riess O; Gasser T; Kögel D; Steinmetz H; Auburger G
Exp Neurol; 2008 Aug; 212(2):307-13. PubMed ID: 18511044
[TBL] [Abstract][Full Text] [Related]
24. Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila.
Wang D; Qian L; Xiong H; Liu J; Neckameyer WS; Oldham S; Xia K; Wang J; Bodmer R; Zhang Z
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13520-5. PubMed ID: 16938835
[TBL] [Abstract][Full Text] [Related]
25. Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice.
Feligioni M; Mango D; Piccinin S; Imbriani P; Iannuzzi F; Caruso A; De Angelis F; Blandini F; Mercuri NB; Pisani A; Nisticò R
Synapse; 2016 Jun; 70(6):223-30. PubMed ID: 26850695
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1).
Sim CH; Gabriel K; Mills RD; Culvenor JG; Cheng HC
Hum Mutat; 2012 Oct; 33(10):1408-22. PubMed ID: 22644621
[TBL] [Abstract][Full Text] [Related]
27. Intranasal administration of rotenone in mice attenuated olfactory functions through the lesion of dopaminergic neurons in the olfactory bulb.
Sasajima H; Miyazono S; Noguchi T; Kashiwayanagi M
Neurotoxicology; 2015 Dec; 51():106-15. PubMed ID: 26493152
[TBL] [Abstract][Full Text] [Related]
28. Loss of Non-Apoptotic Role of Caspase-3 in the PINK1 Mouse Model of Parkinson's Disease.
Imbriani P; Tassone A; Meringolo M; Ponterio G; Madeo G; Pisani A; Bonsi P; Martella G
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336695
[TBL] [Abstract][Full Text] [Related]
29. PINK1 positively regulates HDAC3 to suppress dopaminergic neuronal cell death.
Choi HK; Choi Y; Kang H; Lim EJ; Park SY; Lee HS; Park JM; Moon J; Kim YJ; Choi I; Joe EH; Choi KC; Yoon HG
Hum Mol Genet; 2015 Feb; 24(4):1127-41. PubMed ID: 25305081
[TBL] [Abstract][Full Text] [Related]
30. Evidence of Neurobiological Changes in the Presymptomatic PINK1 Knockout Rat.
Ferris CF; Morrison TR; Iriah S; Malmberg S; Kulkarni P; Hartner JC; Trivedi M
J Parkinsons Dis; 2018; 8(2):281-301. PubMed ID: 29710734
[TBL] [Abstract][Full Text] [Related]
31. Impaired sense of smell in a Drosophila Parkinson's model.
Poddighe S; Bhat KM; Setzu MD; Solla P; Angioy AM; Marotta R; Ruffilli R; Marrosu F; Liscia A
PLoS One; 2013; 8(8):e73156. PubMed ID: 24009736
[TBL] [Abstract][Full Text] [Related]
32. Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease.
Stauch KL; Totusek S; Farmer T; Lamberty BG; Dyball KN; Almikhlafi MA; Fox HS
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33522500
[TBL] [Abstract][Full Text] [Related]
33. TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency.
Flinn LJ; Keatinge M; Bretaud S; Mortiboys H; Matsui H; De Felice E; Woodroof HI; Brown L; McTighe A; Soellner R; Allen CE; Heath PR; Milo M; Muqit MM; Reichert AS; Köster RW; Ingham PW; Bandmann O
Ann Neurol; 2013 Dec; 74(6):837-47. PubMed ID: 24027110
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells.
Rojas-Charry L; Cookson MR; Niño A; Arboleda H; Arboleda G
Neurotoxicology; 2014 Sep; 44():140-8. PubMed ID: 24792327
[TBL] [Abstract][Full Text] [Related]
35. Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction.
Zhi L; Qin Q; Muqeem T; Seifert EL; Liu W; Zheng S; Li C; Zhang H
Neurobiol Aging; 2019 Mar; 75():1-10. PubMed ID: 30504091
[TBL] [Abstract][Full Text] [Related]
36. Ischemic injury precipitates neuronal vulnerability in Parkinson's disease: Insights from PINK1 mouse model study and clinical retrospective data.
Imbriani P; D'Angelo V; Platania P; Di Lazzaro G; Scalise S; Salimei C; El Atiallah I; Colona VL; Mercuri NB; Bonsi P; Pisani A; Schirinzi T; Martella G
Parkinsonism Relat Disord; 2020 May; 74():57-63. PubMed ID: 32335490
[TBL] [Abstract][Full Text] [Related]
37. Ultrasound-based motion analysis demonstrates bilateral arm hypokinesia during gait in heterozygous PINK1 mutation carriers.
Nürnberger L; Klein C; Baudrexel S; Roggendorf J; Hildner M; Chen S; Kang JS; Hilker R; Hagenah J
Mov Disord; 2015 Mar; 30(3):386-92. PubMed ID: 25545816
[TBL] [Abstract][Full Text] [Related]
38. PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity.
Madeo G; Schirinzi T; Martella G; Latagliata EC; Puglisi F; Shen J; Valente EM; Federici M; Mercuri NB; Puglisi-Allegra S; Bonsi P; Pisani A
Mov Disord; 2014 Jan; 29(1):41-53. PubMed ID: 24167038
[TBL] [Abstract][Full Text] [Related]
39. Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement.
Matsui H; Taniguchi Y; Inoue H; Kobayashi Y; Sakaki Y; Toyoda A; Uemura K; Kobayashi D; Takeda S; Takahashi R
Neurosci Res; 2010 Feb; 66(2):151-61. PubMed ID: 19895857
[TBL] [Abstract][Full Text] [Related]
40. Early-onset Parkinsonian behaviors in female Pink1-/- rats.
Marquis JM; Lettenberger SE; Kelm-Nelson CA
Behav Brain Res; 2020 Jan; 377():112175. PubMed ID: 31542395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
